p53 mutations versus EGF receptor expression in giant cell glioblastomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 11, 1997, Pages 1236-1241

  Peraud, Aurelia ^a   Watanabe, Kunihiko ^a   Plate, Karl H ^d   Yonekawa, Yasuhiro ^c   Kleihues, Paul ^a,b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

EGF receptor overexpression; Giant cell glioblastoma; p53 mutation; Primary glioblastoma; Secondary glioblastoma

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GIANT CELL TUMOR; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030729006     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199711000-00008     Document Type: Article

References (31)

1. Scherer HJ. Cerebral astrocytomas and their derivatives. Am J Cancer 1940;40:159-98
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68
3. Daumas Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62: 2152-65
4. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-24
5. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H. Amplification and Overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 1996;56:180-85
6. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-36
7. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26
8. Palma L, Celli P, Maleci A, Di Lorenzo N, Cantore G. Malignant monstrocellular brain tumours. A study of 42 surgically treated cases. Acta Neurochir Wien 1989;97:17-25
9. Gherardi R, Baudrimont M, Nguyen JP, et al. Monstrocellular heavily lipidized malignant glioma. Acta Neuropathol (Berl) 1986; 69:28-32
10. Tsao MS, Becker L, Finlayson M. Giant cell astrocytoma with histiocytic infiltrate. Acta Neuropathol (Berl) 1983;59:75-77
11. Garcia-Bengochea F, Collins GH. Monstrocellular sarcoma of the brain: 6-year postoperative survival. J Neurosurg 1969;31:686-89
12. Hadfield MG, Silverberg SG. Light and electron microscopy of giant-cell glioblastoma. Cancer 1972;30:989-96
13. Zulch KJ. Histological typing of tumours of the central nervous system. Geneva: World Health Organization, 1979
14. Zulch KJ. Brain tumors. Their biology and pathology. 3rd ed. Berlin Heidelberg: Springer Verlag, 1986
15. Jaque CM, Kujas M, Poreau A, et al. GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas. J Natl Cancer Inst 1979;62:479-83
16. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin Heidelberg: Springer Verlag, 1993
17. Margetts JC, Kalyan Raman UP. Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer 1989;63: 524-31
18. Bingas B. Das monstrocellulaere Sarkom des Gehirns. Arch Psychiatr Nervenkr 1964;205:223-36
19. Herberg J, Sotrel A, Brody BA, Welch K. Early-onset monstrocellular astrocytoma with favorable course. J Neuropathol Exp Neurol 1984;43:338
20. Bigner SH, Mark J, Schold SC, Jr., Eng LF, Bigner DD. A serially transplantable human giant cell glioblastoma that maintains a near-haploid stem line. Cancer Genet Cytogenet 1985;18:141-53
21. Bigner SH, Burger PC, Wong AJ, et al. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects. J Neuropathol Exp Neurol 1988;47:191-205
22. Kawano H, Kubota T, Sato K, Goya T, Arikawa S, Wakisaka S. Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol 1995;14:118-23
23. Hunter SB, Bandea C, Swan D, Abbott K, Varma VA. Mutations in the p53 gene in human astrocytomas: Detection by single-strand conformation polymorphism analysis and direct DNA sequencing. Mod Pathol 1993;6:442-45
24. Rideout WM III, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-90
25. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64
26. Muller W, Slowik F, Firsching R, Afra D, Sanker P. Contribution to the problem of giant cell astrocytomas. Neurosurg Rev 1987;10: 213-19
27. Burger PC, Scheithauer BW. Tumors of the central nervous system. Washington: Armed Forces Institute of Pathology, 1994
28. Lantos PL, VandenBerg SR, Kleihues P. Tumours of the nervous system. Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6th ed. London: Arnold, 1996;9:583-79
29. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. London: Edward Arnold, 1989
30. Louis DN, Rubio MP, Correa KM, Gusella JF, von Deimling A. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 1993;52:507-15
31. Sure U, Ruedi D, Tachibana O, et al. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropath Exp Neurol 1997;56:782-89